{"id":"https://openalex.org/W2473239481","doi":"https://doi.org/10.1017/s1092852900014024","title":"Effectiveness of Long-Term Augmentation with Citalopram to Clomipramine in Treatment-Resistant OCD Patients","display_name":"Effectiveness of Long-Term Augmentation with Citalopram to Clomipramine in Treatment-Resistant OCD Patients","publication_year":2008,"publication_date":"2008-11-01","ids":{"openalex":"https://openalex.org/W2473239481","doi":"https://doi.org/10.1017/s1092852900014024","mag":"2473239481","pmid":"https://pubmed.ncbi.nlm.nih.gov/19037176"},"language":"en","primary_location":{"id":"doi:10.1017/s1092852900014024","doi":"https://doi.org/10.1017/s1092852900014024","is_oa":false,"landing_page_url":"https://doi.org/10.1017/s1092852900014024","pdf_url":null,"source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012010863","display_name":"Donatella Marazziti","orcid":"https://orcid.org/0000-0002-4021-5829","observed_orcids":["https://orcid.org/0000-0002-4021-5829"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Donatella Marazziti","raw_affiliation_strings":["Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Italy. dmarazzi@psico.med.unipi.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Italy. dmarazzi@psico.med.unipi.it","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Francesco Golia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Golia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057972536","display_name":"Giorgio Consoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giorgio Consoli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065840333","display_name":"Silvio Presta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvio Presta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026077616","display_name":"Chiara Pfanner","orcid":"https://orcid.org/0000-0002-6970-3578","observed_orcids":["https://orcid.org/0000-0002-6970-3578"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiara Pfanner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030540954","display_name":"Marina Carlini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Carlini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102931732","display_name":"Francesco Mungai","orcid":"https://orcid.org/0000-0001-8790-0252","observed_orcids":["https://orcid.org/0000-0001-8790-0252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Mungai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086314215","display_name":"Mario Catena Dell\u2019Osso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Catena Dell'Osso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":2.2252,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.88248203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"13","issue":"11","first_page":"971","last_page":"976"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-resistant-ocd","display_name":"treatment-resistant OCD","score":0.9509999752044678},{"id":"https://openalex.org/keywords/citalopram","display_name":"citalopram","score":0.8740000128746033},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":1.0},{"id":"https://openalex.org/keywords/pharmacological-augmentation","display_name":"drug augmentation","score":0.6600000262260437},{"id":"https://openalex.org/keywords/serotonergic-drugs","display_name":"serotonergic drugs","score":0.7020000219345093},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/y-bocs","display_name":"Yale-Brown Obsessive Compulsive Scale","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.753000020980835},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.9061214327812195},{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.816009521484375},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7882710695266724},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.5972934365272522},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.5384359955787659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5158554911613464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4662075936794281},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.44518256187438965},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4346640110015869},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40831801295280457},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3845292925834656},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.24999651312828064},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22312521934509277},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.16154742240905762},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015283","descriptor_name":"Citalopram","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015283","descriptor_name":"Citalopram","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1017/s1092852900014024","doi":"https://doi.org/10.1017/s1092852900014024","is_oa":false,"landing_page_url":"https://doi.org/10.1017/s1092852900014024","pdf_url":null,"source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},{"id":"pmid:19037176","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19037176","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS spectrums","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W28870578","https://openalex.org/W34351768","https://openalex.org/W92996275","https://openalex.org/W183177044","https://openalex.org/W1664173751","https://openalex.org/W1710919659","https://openalex.org/W1966161934","https://openalex.org/W1970854365","https://openalex.org/W1971097055","https://openalex.org/W1984255668","https://openalex.org/W2001166189","https://openalex.org/W2006001020","https://openalex.org/W2008585613","https://openalex.org/W2011811397","https://openalex.org/W2043628210","https://openalex.org/W2045269494","https://openalex.org/W2056251434","https://openalex.org/W2061314614","https://openalex.org/W2065955580","https://openalex.org/W2069929468","https://openalex.org/W2077145937","https://openalex.org/W2079129034","https://openalex.org/W2082593045","https://openalex.org/W2087854982","https://openalex.org/W2087906691","https://openalex.org/W2092648004","https://openalex.org/W2096203343","https://openalex.org/W2100202859","https://openalex.org/W2114570941","https://openalex.org/W2114613490","https://openalex.org/W2129381808","https://openalex.org/W2168653618","https://openalex.org/W2225152148","https://openalex.org/W2230515130","https://openalex.org/W2254935112","https://openalex.org/W2283532010","https://openalex.org/W2407736134","https://openalex.org/W2477404806","https://openalex.org/W3090293687","https://openalex.org/W4245860082"],"related_works":["https://openalex.org/W1970854365","https://openalex.org/W2312643292","https://openalex.org/W3024621224","https://openalex.org/W37747787","https://openalex.org/W2017330356","https://openalex.org/W2467738672","https://openalex.org/W1982472872","https://openalex.org/W2371998373","https://openalex.org/W1970026786","https://openalex.org/W7141321248"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,44,121,171,187],"high":[2],"percentage":[3],"(between":[4],"40%":[5],"and":[6,62,76,103,130,141,162,166,204,220,241,246],"60%)":[7],"of":[8,29,51,64,79,85,118,147,179,193,201,208,227,234],"resistance":[9],"to":[10,57,90,92],"first-line":[11],"drugs,":[12],"such":[13],"as":[14,175],"clomipramine":[15,107],"or":[16],"selective":[17,99],"serotonin":[18,100],"reuptake":[19,101],"inhibitors,":[20],"is":[21,257],"a":[22,74,98,115,176,217],"major":[23],"problem":[24],"in":[25,66,216,221,238,255],"the":[26,49,59,132,148,163,180,194,228,232],"pharmacologic":[27],"management":[28],"obsessive-compulsive":[30],"disorder":[31],"(OCD).":[32],"In":[33],"these":[34],"cases,":[35],"different":[36,109],"strategies":[37],"have":[38],"been":[39],"employed":[40],"with":[41,73,97,231],"controversial":[42],"outcomes.":[43],"meager":[45],"information":[46],"available":[47],"on":[48,252],"association":[50,233,254],"two":[52,95,235],"serotonergic":[53,236],"drugs":[54],"prompted":[55],"us":[56],"explore":[58],"possible":[60],"effectiveness":[61],"tolerability":[63,248],"citalopram+clomipramine":[65],"resistant":[67,239],"OCD":[68,240,256],"patients.":[69],"METHODS:":[70],"Twenty":[71],"outpatients":[72],"Diagnostic":[75],"Statistical":[77],"Manual":[78],"Mental":[80],"Disorders,":[81],"Fourth":[82],"Edition":[83],"diagnosis":[84],"OCD,":[86],"who":[87],"had":[88],"failed":[89],"respond":[91],"at":[93,108,114,127,131],"least":[94],"trials":[96],"inhibitor":[102],"were":[104,111],"currently":[105],"taking":[106],"doses,":[110],"administered":[112],"citalopram":[113],"maximum":[116],"dose":[117],"60":[119],"mg/day.":[120],"clinical":[122],"assessment":[123],"was":[124,173],"carried":[125,214],"out":[126,215],"baseline":[128],"(t0)":[129],"4th":[133],"(t1),":[134],"12th":[135],"(t2),":[136],"24th":[137],"(t3),":[138],"36th":[139],"(t4),":[140],"48th":[142],"(t5)":[143],"week":[144],"by":[145],"means":[146],"Yale-Brown":[149,181],"Obsessive":[150],"Compulsive":[151],"Scale,":[152],"Hamilton":[153],"Rating":[154],"Scale":[155,183],"for":[156],"Depression,":[157],"Clinical":[158],"Global":[159],"Impression":[160],"scale,":[161],"Dosage":[164],"Record":[165],"Treatment":[167],"Emergent":[168],"Symptom":[169],"Scale.":[170],"response":[172],"defined":[174],"35%":[177],"decrease":[178],"Obsessive-Compulsive":[182],"total":[184],"score.":[185],"RESULTS:":[186],"results":[188],"showed":[189],"that":[190],"approximately":[191],"50%":[192],"patients":[195],"improved":[196],"significantly":[197],"after":[198,205],"1":[199,206],"month":[200],"this":[202,253],"regimen":[203],"year":[207],"treatment.":[209],"CONCLUSION:":[210],"This":[211],"study,":[212],"although":[213],"small":[218],"sample":[219],"an":[222],"open":[223],"fashion,":[224],"represents":[225],"one":[226],"few":[229],"experiences":[230],"compounds":[237],"confirms":[242],"its":[243],"potential":[244],"usefulness":[245],"good":[247],"profile.":[249],"Controlled":[250],"research":[251],"recommended.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-07-22T00:00:00"}